Use of long acting pain relieving agents in patients having surgery for gap in upper jaw

Evaluating efficacy of Pre-emptive Tranexamic acid infusion with Ropivacaine to minimise blood loss and post operative pain in children undergoing palatoplasty - Nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2024/03/064239

Enrollment

Registered

2024-03-15

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: Q359- Cleft palate, unspecified

Interventions

Intervention1: Ropivacaine+ Tranexamic acid: Ropivacaine 2% , Local infiltration with maximum dose of 3mg/kg. Control Intervention1: Lignocaine + Tranexamic acid: Lignocaine 2& as local infiltration.

Eligibility

Inclusion criteria

Inclusion criteria: Primary cleft palate Non syndromic patients No bleeding disorders

Exclusion criteria

Exclusion criteria: Palatal fistula Syndromic patients Patients with bleeding disorders

Design outcomes

Primary

Measure	Time frame
Intraoperative blood loss, Post operative painTimepoint: 2,4, 6, 8, 12, 24 Hours	—

Secondary

Measure	Time frame
Surgeons comfort, patients comfort, intra operative vitalsTimepoint: At 1hour, 6hour, 12hour, & 24 hours post operatively	—

Countries

India

Contacts

Public ContactDr Aditya Hurkat

Saveetha dental college and hospitals

vinodkrishna.sdc@saveetha.com9925012656

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026